The estimated Net Worth of Mark Brister is at least $108 mil dollars as of 6 August 2019. Mark Brister owns over 5,000 units of Obalon Therapeutics Inc stock worth over $107,656 and over the last 19 years Mark sold OBLN stock worth over $0.
Mark has made over 1 trades of the Obalon Therapeutics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Mark bought 5,000 units of OBLN stock worth $20,000 on 6 August 2019.
The largest trade Mark's ever made was buying 5,000 units of Obalon Therapeutics Inc stock on 6 August 2019 worth over $20,000. On average, Mark trades about 333 units every 0 days since 2005. As of 6 August 2019 Mark still owns at least 38,865 units of Obalon Therapeutics Inc stock.
You can see the complete history of Mark Brister stock trades at the bottom of the page.
Mark's mailing address filed with the SEC is C/O OBALON THERAPEUTICS, INC., 5421 AVENIDA ENCINAS, SUITE F, CARLSBAD, CA, 92008.
Over the last 8 years, insiders at Obalon Therapeutics Inc have traded over $0 worth of Obalon Therapeutics Inc stock and bought 3,260,355 units worth $6,939,913 . The most active insiders traders include Parters Vii L Pblair James ..., Partners X Lp Inter West Ma... y David Moatazedi. On average, Obalon Therapeutics Inc executives and independent directors trade stock every 54 days with the average trade being worth of $432,771. The most recent stock trade was executed by William J. Plovanic on 12 November 2019, trading 65,000 units of OBLN stock currently worth $107,900.
Obalon Therapeutics, Inc. is a San Diego-based company focused on developing and commercializing novel technologies for weight loss.
Obalon Therapeutics Inc executives and other stock owners filed with the SEC include: